CEN Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep '22 Sep 30, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	0.15	0.19	0	0	0	0.08
Cash & Short-Term Investments	0.15	0.19	0	0	0	0.08
Cash Growth	-30.71%	10025.68%	-49.21%	17.66%	-96.24%	36.22%
Accounts Receivable	0.01	0.19	-	-	-	-
Other Receivables	0.03	0.04	-	-	-	-
Receivables	0.05	0.23	0.02	-	-	-
Prepaid Expenses	0.11	0.05	-	-	-	-
Total Current Assets	0.3	0.47	0.02	0	0	0.08
Property, Plant & Equipment	0.16	0.24	-	0.38	0.17	1.45
Goodwill	1.28	1.31	-	-	-	-
Other Intangible Assets	4.82	5.07	4.96	5.38	5.81	6.23
Long-Term Deferred Tax Assets	0	0	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	0.22
Other Long-Term Assets	1.3	1.3	1.29	1.49	1.29	1
Total Assets	7.91	8.44	6.31	7.3	7.31	9.02
Accounts Payable	0.45	0.54	0.2	0.18	0.21	0.09
Accrued Expenses	3.81	3.87	3.38	11.43	8.21	5.44
Short-Term Debt	3.25	3.25	1.62	11.2	11.14	10.86
Current Portion of Long-Term Debt	2.06	1.94	9.48	8.01	4.85	3.63
Current Portion of Leases	0.11	0.1	0.02	0.04	-	-
Current Unearned Revenue	0.14	0.15	-	-	-	-
Total Current Liabilities	9.83	9.86	14.71	30.87	24.41	20.03
Long-Term Debt	0.03	0.03	0.08	1.06	3.16	3.01
Long-Term Leases	0.16	0.21	0.14	0.18	-	-
Other Long-Term Liabilities	-	-	1.38	0.72	1.01	5
Total Liabilities	10.02	10.1	16.31	32.83	28.58	28.04
Additional Paid-In Capital	44.92	44.34	17.07	15.78	14.39	9.11
Retained Earnings	-46.99	-45.96	-27.06	-41.31	-35.66	-28.12
Comprehensive Income & Other	-0.04	-0.03	-	-	-	-
Total Common Equity	-2.11	-1.66	-9.99	-25.54	-21.26	-19.01
Shareholders' Equity	-2.11	-1.66	-9.99	-25.54	-21.26	-19.01
Total Liabilities & Equity	7.91	8.44	6.31	7.3	7.31	9.02
Total Debt	5.62	5.54	11.34	20.5	19.15	17.5
Net Cash (Debt)	-5.47	-5.35	-11.34	-20.49	-19.15	-17.42
Net Cash Per Share	-0.09	-0.13	-0.35	-0.78	-0.76	-2.07
Filing Date Shares Outstanding	64.13	56.41	27.59	27.01	25.52	25.13
Total Common Shares Outstanding	63.99	55.96	27.56	26.95	25.47	25.13
Working Capital	-9.53	-9.39	-14.69	-30.86	-24.4	-19.94
Book Value Per Share	-0.03	-0.03	-0.36	-0.95	-0.83	-0.76
Tangible Book Value	-8.2	-8.04	-14.95	-30.92	-27.07	-25.25
Tangible Book Value Per Share	-0.13	-0.14	-0.54	-1.15	-1.06	-1.00
Machinery	-	0.1	-	0.02	0.02	0.02
Leasehold Improvements	-	0.02	-	0.17	0.17	1.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.